Results 121 to 130 of about 138,877 (380)

Multiple sclerosis and COVID-19 as two triggers of conjunctivitis: a case report [PDF]

open access: bronze, 2023
Mehran Frouzanian   +3 more
openalex   +1 more source

A Clinician’s Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis

open access: yesDrugs in R&D, 2019
Dupilumab, a monoclonal antibody that inhibits both interleukin (IL)-4 and IL-13 signaling, is an effective treatment option in moderate-to-severe atopic dermatitis (AD).
G. Agnihotri, Katherine Shi, P. Lio
semanticscholar   +1 more source

Disseminated Papules in a 40‐Year‐Old Man

open access: yes
JEADV Clinical Practice, EarlyView.
E. Bearzi   +6 more
wiley   +1 more source

Cellular Mechanism and Key Insights in Allergen Immunotherapy for Allergic Rhinitis

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Allergic rhinitis (AR) arises from immune responses mediated by immunoglobulin E (IgE) to inhaled allergens, representing one of the most prevalent chronic conditions worldwide. Although AR may not be a serious ailment, it holds clinical relevance as it underpins numerous complications, serves as a major risk factor for suboptimal asthma ...
Zhe Wang   +3 more
wiley   +1 more source

THE EFFECT OF ALLERGIC CONJUCTIVITIS ON CHOROIDAL THICKNESS

open access: yesSanamed, 2019
Background: To examine the effects of allergic conjunctivitis and its treatment upon choroidal thickness (ChT) using topical antihistaminic agents. Methods: 60 eyes of 30 children and adolescents with allergic conjunctivitis and 60 eyes of 30 healthy ...
Ayyildiz Taha   +2 more
doaj   +1 more source

Use of Topical Steroids in Conjunctivitis: A Review of the Evidence.

open access: yesCornea, 2019
PURPOSE Conjunctivitis, or inflammation of the conjunctiva, is a common condition that can be caused by infectious (eg, bacterial or viral infections) and noninfectious (eg, allergy) etiologies.
E. Holland, M. Fingeret, F. Mah
semanticscholar   +1 more source

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki   +24 more
wiley   +1 more source

Recurrent Meningitis and Its Rare Association With Ligneous Conjunctivitis and Congenital Plasminogen Deficiency [PDF]

open access: diamond, 2023
Somayah A Alghubaishi   +4 more
openalex   +1 more source

Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent remissions and relapses. Topical anti‐inflammatory steroids are commonly used for treatment, but their long‐term use poses concerns because of potential side effects. Delgocitinib ointment, a Janus kinase inhibitor, has demonstrated efficacy in several clinical
Masatoshi Abe   +5 more
wiley   +1 more source

Conjunctivitis in an Individual With Monkeypox.

open access: yesJAMA ophthalmology, 2022
F. Ly-Yang   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy